CIK 0001534120
- Non-accelerated filer
- Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450705648
- Phone
- +1 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $395,474
- in 3 filings, $395K under 10b5-1 plans
Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-08 | Sullivan Christopher Ryan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-03-08 | NEIL GARRY ARTHUR Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,000,000 | 1,000,000 | ||
| 2022-03-07 | ARMISTICE CAPITAL, LLC Director | Purchase | +325,000 | $0.66 | $213K | 47,350,000 |
| 2022-03-04 | ARMISTICE CAPITAL, LLC Director | Purchase | +135,000 | $0.70 | $95K | 47,025,000 |
| 2022-03-03 | ARMISTICE CAPITAL, LLC Director | Purchase | +50,000 | $0.71 | $36K | 46,890,000 |
| 2022-02-25 | ARMISTICE CAPITAL, LLC Director | Purchase | +40,000 | $0.79 | $32K | 46,840,000 |
| 2022-02-24 | ARMISTICE CAPITAL, LLC Director | Purchase | +100,000 | $0.80 | $80K | 46,800,000 |
| 2022-02-22 | ARMISTICE CAPITAL, LLC Director | Purchase | +83,000 | $0.77 | $64K | 46,700,000 |
| 2022-02-18 | ARMISTICE CAPITAL, LLC Director | Purchase | +55,000 | $0.82 | $45K | 46,617,000 |
| 2022-02-17 | ARMISTICE CAPITAL, LLC Director | Purchase | +150,000 | $0.82 | $122K | 46,562,000 |
| 2022-01-20 | ARMISTICE CAPITAL, LLC Director | Purchase | +12,000 | $0.85 | $10K | 46,412,000 |
| 2022-01-19 | ARMISTICE CAPITAL, LLC Director | Purchase | +93,700 | $0.88 | $82K | 46,400,000 |
| 2022-01-18 | ARMISTICE CAPITAL, LLC Director | Purchase | +206,300 | $0.88 | $182K | 46,306,300 |
| 2022-01-14 | ARMISTICE CAPITAL, LLC Director | Purchase | +85,000 | $0.93 | $79K | 46,100,000 |
| 2022-01-13 | ARMISTICE CAPITAL, LLC Director | Purchase | +312,700 | $1.00 | $314K | 46,015,000 |
| 2022-01-12 | ARMISTICE CAPITAL, LLC Director | Purchase | +57,300 | $1.04 | $60K | 45,702,300 |
| 2022-01-11 | ARMISTICE CAPITAL, LLC Director | Purchase | +16,003 | $0.96 | $15K | 45,645,000 |
| 2022-01-10 | ARMISTICE CAPITAL, LLC Director | Purchase | +491,097 | $0.99 | $485K | 45,628,997 |
| 2022-01-07 | ARMISTICE CAPITAL, LLC Director | Purchase | +137,900 | $1.04 | $143K | 45,137,900 |
| 2022-01-04 | Smolinski Stephen Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 |
Page 15 of 25 · 500 trades